172 related articles for article (PubMed ID: 19052394)
21. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
[TBL] [Abstract][Full Text] [Related]
22. Primary non-Hodgkin's lymphoma of the gallbladder diagnosed by laparoscopic cholecystectomy.
Kato H; Naganuma T; Iizawa Y; Kitagawa M; Tanaka M; Isaji S
J Hepatobiliary Pancreat Surg; 2008; 15(6):659-63. PubMed ID: 18987940
[TBL] [Abstract][Full Text] [Related]
23. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Kiewe P; Thiel E
Ann Hematol; 2011 Jan; 90(1):109-10. PubMed ID: 20387065
[No Abstract] [Full Text] [Related]
24. A perplexing primary novel hilar lesion: Remember the pneumonic PPNHL!
Utpat K; Desai UD; Amonkar G; Joshi JM
Indian J Pathol Microbiol; 2018; 61(1):85-89. PubMed ID: 29567890
[TBL] [Abstract][Full Text] [Related]
25. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
26. Primary endometrial non-Hodgkin's lymphoma treated by chemotherapy and radiotherapy.
Guldrís EM; Vázquez P; Fernández A
Acta Obstet Gynecol Scand; 2013 May; 92(5):606. PubMed ID: 23398244
[No Abstract] [Full Text] [Related]
27. [Primary malignant non-Hodgkin's lymphoma of the heart].
Iwuagwu OC; Kober R
Rofo; 2002 Dec; 174(12):1578-9. PubMed ID: 12471533
[No Abstract] [Full Text] [Related]
28. An atypical presentation of an ovarian lymphoma: a case report.
Ekanayake CD; Punchihewa R; Wijesinghe PS
J Med Case Rep; 2018 Nov; 12(1):338. PubMed ID: 30424819
[TBL] [Abstract][Full Text] [Related]
29. Primary diffuse large B-cell lymphoma of the cranial vault with Trousseau syndrome: a case report.
Uchida T; Amagasaki K; Hosono A; Nakaguchi H
J Med Case Rep; 2021 Aug; 15(1):431. PubMed ID: 34404459
[TBL] [Abstract][Full Text] [Related]
30. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ
Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197
[TBL] [Abstract][Full Text] [Related]
32. Cure in a case of primary hepatic lymphoma.
Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
[TBL] [Abstract][Full Text] [Related]
33. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
Hagemeister F; Rodriguez MA; Deitcher SR; Younes A; Fayad L; Goy A; Dang NH; Forman A; McLaughlin P; Medeiros LJ; Pro B; Romaguera J; Samaniego F; Silverman JA; Sarris A; Cabanillas F
Br J Haematol; 2013 Sep; 162(5):631-8. PubMed ID: 23802738
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Spina M; Simonelli C; Tirelli U
J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
[No Abstract] [Full Text] [Related]
35. Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
Burney IA; Malik IA
J Pak Med Assoc; 1996 Jan; 46(1):14-5. PubMed ID: 8830160
[No Abstract] [Full Text] [Related]
36. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
37. CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Prayoonwiwat W; Numbenjapon T; Assawametha N; O'Charoen R; Swasdikul D
Clin Lymphoma; 2000 Dec; 1(3):219-25. PubMed ID: 11707834
[TBL] [Abstract][Full Text] [Related]
38. Primary sacral non-Hodgkin's lymphoma: report of a case and systematic review of literature.
Chigurupati SV; Shukla M; Pandey M
World J Surg Oncol; 2021 Feb; 19(1):61. PubMed ID: 33627139
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Jabbour E; Peslin N; Arnaud P; Ferme C; Carde P; Vantelon JM; Bocaccio C; Bourhis JH; Koscielny S; Ribrag V
Leuk Lymphoma; 2005 Jun; 46(6):861-7. PubMed ID: 16019530
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Zheng SM; Zhou DJ; Chen YH; Jiang R; Wang YX; Zhang Y; Xue HL; Wang HQ; Mou D; Zeng WZ
World J Gastroenterol; 2017 Jun; 23(24):4467-4472. PubMed ID: 28706431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
